This article was originally published in The Gray Sheet
Company's Surgitek Division receives FDA approval for its Ultragold urological laser fiber "for laser ablation of soft tissue within the urinary tract to alleviate bladder outlet obstruction." The fiber, Cabot notes, "is becoming widely used by urologists, on an experimental basis, for treatment of BPH (benign prostatic hyperplasia)," but "has not yet been approved...for this specific procedure"
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.